Location · Miami, FL
Clinical trials in Miami, FL
864 recruiting studies have a site in the Miami area, and 187 of them accept healthy volunteers. The area includes Miami Beach, Coral Gables, Hialeah, Miami Lakes, Doral, Aventura and nearby cities.
864 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 4
Secukinumab Open Label Roll-over Extension Protocol
Novartis Pharmaceuticals
- Location
- Boca Raton, FL + 1 other US site
- Eligibility basics
- Ages 6–100
- RecruitingPhase 3
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Novartis Pharmaceuticals
- Location
- Anniston, AL + 20 other US sites
- Eligibility basics
- Ages 12–100
- RecruitingPhase 3
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Sanofi
- Location
- Palo Alto, CA + 14 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
AstraZeneca
- Location
- Alexander City, AL + 93 other US sites
- Eligibility basics
- Ages 18–130
- RecruitingPhase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca
- Location
- Anchorage, AK + 70 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Birmingham, AL + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Regeneron Pharmaceuticals
- Location
- Chandler, AZ + 144 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Cytokinetics
- Location
- Alexander City, AL + 80 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Scottsdale, AZ + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- Phoenix, AZ + 90 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Cook Research Incorporated
- Location
- Long Beach, CA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- San Francisco, CA + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 1
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
Merck Sharp & Dohme LLC
- Location
- Birmingham, AL + 20 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 42 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Merck Sharp & Dohme LLC
- Location
- Los Angeles, CA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sanofi
- Location
- Cullman, AL + 33 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
LEO Pharma
- Location
- Birmingham, AL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Hoffmann-La Roche
- Location
- Guntersville, AL + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Boehringer Ingelheim
- Location
- Huntsville, AL + 15 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Axsome Therapeutics, Inc.
- Location
- Tucson, AZ + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
AstraZeneca
- Location
- Bakersfield, CA + 11 other US sites
- Eligibility basics
- Ages 4–11
- RecruitingPhase 3
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC
- Location
- Anaheim, CA + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
Enlivex Therapeutics Ltd.
- Location
- Longwood, FL + 3 other US sites
- Eligibility basics
- Ages 64+